Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ene Ette"'
Autor:
Douglas Blayney, Qingyuan Zhang, Ramon Mohanlal, Lihua Du, Ene Ette, Stephan Ogenstad, Hryhoriy Adamchuk, Tao Sun, Hongsheng Li, Jifen Feng, Lan Huang, Yuan-kai Shi
PurposePlinabulin is a non-granulocyte colony-stimulating factor (G-CSF) novel small molecule with both anticancer and myeloprotective effects. Single-agent plinabulin is myeloprotective in the first week of the chemotherapy cycle, and pegfilgrastim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::504a9b2ef390bf4a44ea12187a96eeed
https://doi.org/10.21203/rs.3.rs-1178705/v1
https://doi.org/10.21203/rs.3.rs-1178705/v1
Autor:
Lihua Du, Ene Ette, Ramon Mohanlal, Dmitriy Petrovich Udovista, Jifeng Feng, Qingyuan Zhang, Santosh Nair, Igor Bondarenko, Yanqiu Zhao, Nadezhda Kovalenko, Ihor Vynnychenko, Stephan Ogenstad, Douglas W. Blayney, Emad Ibrahim, Lan Huang, Yuankai Shi
Publikováno v:
JAMA Oncol
IMPORTANCE: Plinabulin is a novel, non–granulocyte colony-stimulating factor (GCSF) small molecule with both anticancer and neutropenia-prevention effects. OBJECTIVE: To assess the efficacy and safety of plinabulin compared with pegfilgrastim for t
Autor:
David M. Albala, Hani Rashid, Ashok C. Chander, Stephen M. Zappala, Naveen Kella, Jonathan S. Varsanik, Ene Ette, Grannum R. Sant, Vladimir Mouraviev, Michael S. Manak, Kimberly M. Rieger-Christ
Publikováno v:
Urology. 124
Objective To examine the ability of a novel live primary-cell phenotypic (LPCP) test to predict postsurgical adverse pathology (P-SAP) features and risk stratify patients based on SAP features in a blinded study utilizing radical prostatectomy (RP) s
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
John, Orloff, Frank, Douglas, Jose, Pinheiro, Susan, Levinson, Michael, Branson, Pravin, Chaturvedi, Ene, Ette, Paul, Gallo, Gigi, Hirsch, Cyrus, Mehta, Nitin, Patel, Sameer, Sabir, Stacy, Springs, Donald, Stanski, Matthias R, Evers, Edd, Fleming, Navjot, Singh, Tony, Tramontin, Howard, Golub
Publikováno v:
Nature reviews. Drug discovery. 8(12)
Declining pharmaceutical industry productivity is well recognized by drug developers, regulatory authorities and patient groups. A key part of the problem is that clinical studies are increasingly expensive, driven by the rising costs of conducting P
Autor:
John G, McHutchison, Mitchell L, Shiffman, Ramsey C, Cheung, Stuart C, Gordon, Teresa L, Wright, John C, Pottage, Lindsay, McNair, Ene, Ette, Scott, Moseley, John, Alam
Publikováno v:
Antiviral therapy. 10(5)
Inhibition of inosine monophosphate dehydrogenase (IMPDH) is one of several proposed mechanisms of action for ribavirin (RBV), a critical component of the current treatment for chronic hepatitis C (CHC). This study was a double-blind, placebo-control
Autor:
Paul Williams, Ene Ette
Publikováno v:
Drugs and the Pharmaceutical Sciences ISBN: 9780824708627
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99b3aec7596e9d63617f2f727fc7460b
https://doi.org/10.1201/9780203910276.ch5
https://doi.org/10.1201/9780203910276.ch5
Publikováno v:
Drugs and the Pharmaceutical Sciences ISBN: 9780824708627
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6998970eb02e25ba8ed87870d8c252cd
https://doi.org/10.1201/9780203910276.ch7
https://doi.org/10.1201/9780203910276.ch7
Autor:
Deborah, Toppmeyer, Andrew D, Seidman, Michael, Pollak, Christy, Russell, Katherine, Tkaczuk, Shailendra, Verma, Beth, Overmoyer, Varun, Garg, Ene, Ette, Matthew W, Harding, George D, Demetri
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 8(3)
VX-710 (biricodar, Incel) restores drug sensitivity to P-glycoprotein (MDR1) and multidrug resistance-associated protein (MRP1)-expressing cells. This Phase II study evaluated the safety/tolerability, pharmacokinetics, and efficacy of VX-710 plus pac
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.